We serve Chemical Name:4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE CAS:1005-39-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE
CAS.NO:1005-39-6
Synonyms:EINECS 213-735-9;4,6-Diamino-2-methylmercaptopyrimidine;MFCD00023241;2-methylsulfanylpyrimidine-4,6-diamine
Molecular Formula:C5H8N4S
Molecular Weight:156.20900
HS Code:2933599090
Physical and Chemical Properties:
Melting point:189-193ºC
Boiling point:413.5ºC at 760mmHg
Density:1.38g/cm3
Index of Refraction:1.671
PSA:103.12000
Exact Mass:156.04700
LogP:1.52530
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811
Packing Group:III
Contact us for information like EINECS 213-735-9 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-methylsulfanylpyrimidine-4,6-diamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00023241 Use and application,4,6-Diamino-2-methylmercaptopyrimidine technical grade,usp/ep/jp grade.
Related News: However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. 9(10H)-Anthracenone, 8-hydroxy-1,3-dimethyl- manufacturers SAN FRANCISCO–(BUSINESS WIRE)–BetterUp, the inventor of virtual coaching and the first to democratize professional coaching across the entire enterprise, announced today that it is putting down roots in Europe with two new offices in Munich and London. 3-Mercapto-6,7-diphenyl-1,2,4-triazolo(4,3-b)(1,2,4)triazine suppliers AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added. (S)-16-[1-Fluoro-meth-(E)-ylidene]-11,17-dihydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-cyclopenta[a]phenanthren-3-one vendor & factory.
